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Abstract
Background: Cigarette smoking has severe adverse health consequences in adults and in the offspring of mothers
who smoke during pregnancy. One of the most widely reported effects of smoking during pregnancy is reduced
birth weight which is in turn associated with chronic disease in adulthood. Epigenome-wide association studies
have revealed that smokers show a characteristic “smoking methylation pattern”, and recent authors have proposed
that DNA methylation mediates the impact of maternal smoking on birth weight. The aims of the present study
were to replicate previous reports that methylation mediates the effect of maternal smoking on birth weight, and
for the first time to investigate whether the observed mediation effects are sex-specific in order to account for
known sex-specific differences in methylation levels.
Methods: Methylation levels in the cord blood of 313 newborns were determined using the Illumina
HumanMethylation450K Beadchip. A total of 5,527 CpG sites selected on the basis of evidence from the literature
were tested. To determine whether the observed association between maternal smoking and birth weight was
attributable to methylation, mediation analyses were performed for significant CpG sites. Separate analyses were
then performed in males and females.
Results: Following quality control, 282 newborns eventually remained in the analysis. A total of 25 mothers had
smoked consistently throughout the pregnancy. The birthweigt of newborns whose mothers had smoked
throughout pregnancy was reduced by >200g. After correction for multiple testing, 30 CpGs showed differential
methylation in the maternal smoking subgroup including top “smoking methylation pattern” genes AHRR, MYO1G,
GFI1, CYP1A1, and CNTNAP2. The effect of maternal smoking on birth weight was partly mediated by the
methylation of cg25325512 (PIM1); cg25949550 (CNTNAP2); and cg08699196 (ITGB7). Sex-specific analyses revealed a
mediating effect for cg25949550 (CNTNAP2) in male newborns.
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Conclusion: The present data replicate previous findings that methylation can mediate the effect of maternal
smoking on birth weight. The analysis of sex-dependent mediation effects suggests that the sex of the newborn
may have an influence. Larger studies are warranted to investigate the role of both the identified differentially
methylated loci and the sex of the newborn in mediating the association between maternal smoking during
pregnancy and birth weight.
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Background
Cigarette smoking has severe adverse health consequences
in adults and in the offspring of mothers who smoke dur-
ing pregnancy [1]. Despite the efforts of advisory boards
to inform women of the risk to the developing fetus,
around 10% of mothers continue to smoke during preg-
nancy [https://www.cdc.gov/prams/]. Previous research
has identified associations between maternal smoking
during pregnancy and a range of health problems in the
offspring [2, 3]. One of the most widely reported effects is
low birth weight [4–6]. Low birth weight has in turn been
associated with various long-term health problems in
adulthood. These include increased vulnerability to stress
[7], cognitive deficits [8], and chronic somatic disorders,
such as cardiovascular disease [9, 10], and obesity [11].
Low birth weight has also been associated with psychiatric
disorders, such as schizophrenia and depression [12, 13].
On the basis of such research, previous authors have pro-
posed that chronic disease in adulthood may be initiated
during pregnancy as a result of exposure to adverse
intrauterine conditions. According to the theory of “fetal
programming”, alterations in fetal nutrition and endocrine
status result in developmental adaptations, which cause
permanent changes in cellular structure, physiology,
and metabolism, thereby predisposing to disease in
adult life [14, 15].
A plausible mechanism through which exposure to ad-
verse intrauterine conditions may negatively impact
longterm health is DNA methylation. Candidate CpG in-
vestigations and epigenome-wide association studies
(EWAS) have found consistent associations between
smoking and differential DNA methylation in adults
[16–18]. A number of studies have also investigated the
impact of maternal smoking during pregnancy on
methylation patterns in the offspring. These investiga-
tions have comprised candidate gene and genome wide
approaches [19–23], as well as EWAS [24–31]. In these
EWAS, a number of differentially methylated genes have
shown repeated and consistent association [32–34]. The
top five genes are AHRR, GFI1, MYO1G, CYP1A1, and
CNTNAP2.
Previous authors have formulated the hypothesis that
maternal smoking impacts birth weight via smoking-
induced DNA methylation. According to this theory,
differential methylation functions as a mediator, i.e., a
variable that accounts for part of the relation between the
predictor and the criterion [35, 36]. Initial analyses to
determine whether DNA methylation mediates between
maternal smoking and birth weight have already been
performed. In these investigations, a mediation effect was
found for eight CpGs in an analysis of infant cord blood
[37], and two CpGs in an analysis of the placenta [38].
The aims of the present study were to replicate the
previously reported mediating effects of methylation on
the association between maternal smoking and
birth weight, and for the first time to investigate whether
the observed mediation effects are sex-specific. The ana-
lyses focused on high confidence smoking-related sites,
and were restricted to CpG sites with: (i) significant as-
sociation with smoking in a large recent meta-analysis
[31]; or (ii) a reported mediating effect in the association
between maternal smoking and birth weight [37, 38].
Analyses were also performed to determine whether
the observed mediation effects were sex-specific, since:
(i) methylation levels show substantial sex differences
[39]; (ii) the observed sex differences are present from




Data for the present study were derived from the PO-
SEIDON study ("Pre-, peri- and postnatal Stress in hu-
man and non-human offspring: A translational approach
to study Epigenetic Impact on DepressiON"). A detailed
description of the POSEIDON study is provided
elsewhere [41]. The study protocol was approved by the
Ethics Committee of the Medical Faculty Mannheim of
the University of Heidelberg, and the study was con-
ducted in accordance with the Declaration of Helsinki.
Data from 410 mothers and 405 infants recruited during
the third trimester of pregnancy from hospitals in the
Rhine-Neckar Region of Germany were analyzed. Briefly,
maternal exclusion criteria for the present analyses were:
(i) a history of hepatitis B, hepatitis C, or HIV-infection;
(ii) any current or previous diagnosis of schizophrenia or
any substance dependency other than nicotine; and (iii)
any current psychiatric disorder requiring inpatient
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treatment. Exclusion criteria in the offspring were: birth
weight <1.500 g; gestational age at delivery <32 weeks;
multiple birth; and the presence of a congenital disease,
malformation, deformation, or chromosomal abnormality.
A structured interview and a questionnaire battery
were used to collect information concerning environ-
mental-, sociodemographic-, medical-, and psychosocial
risk factors for stress. A detailed description of these in-
struments is provided elsewhere [42]. Sociodemographic
data are presented in the supplement (Additional file 1:
Table S1). For the purposes of the present analyses, the
women were divided into two subgroups: smokers and
non-smokers. The smoking group comprised women
who had smoked throughout pregnancy. The non-
smoking group comprised women who had either not
smoked at all during the pregnancy, or who had smoked
during early pregnancy only. This approach was taken
since previous studies as well as our data have revealed no
differences in the methylation patterns of infants whose
mothers smoked during early pregnancy compared to
infants whose mothers did not smoke at all [43].
Blood collection, DNA extraction, genome-wide
methylation assay
Whole cord blood was collected immediately after birth
from n=313 newborn singletons. For n=299 newborns, au-
tomated genomic DNA extraction was performed using
the chemagic Magnetic Separation Module I (Chemagen
Biopolymer-Technologie AG; Baesweiler; Germany). For
n=14 newborns, a low volume of umbilical cord blood (<2
mL) was obtained. For these 14 samples, DNA was iso-
lated using the QIAamp DNA Blood Midi Kit (Qiagen
GmbH; Hilden; Germany). All genomic DNA samples
were stored at -20 °C prior to analysis.




Quality control (QC) and all statistical analyses were
performed using the R version 3.2.5 statistical analysis
software [44], and the R-packages minfi [45], wateRmelon
[46], Enmix [47], sva [48], limma [49], and mediation [50].
Data preprocessing, QC, and filtering
Methylation intensity signals were extracted from raw
intensity data using the preprocessENmix procedure
[47]. This includes background noise correction using
out-of-band Infinium1 intensities as well as correction
for dye bias based on internal control probes [51]. Data
were then quantile normalized followed by Beta Mixture
Quantile Dilation [BMIQ] [52]. Samples with insufficient
DNA quality (average of medians of methylated and
unmethylated signals <10.5; outlier status with regard to
either averaged total intensity values or beta value
distribution; insufficient bisulfite conversion; or failure
in detection (detection P-value > 0.01) at more than 1%
of positions) were excluded. Probes were excluded if any
of the following criteria were met: beadcount <3; detec-
tion failure in more than 1% of samples; located within
10bp of a single nucleotide polymorphism (SNP); cross
reactivity; X- or Y- linked status.
Data transformation, batch correction, and cell type
adjustment
For all downstream analyses, methylation intensity data
were converted to M-Values [53]. To detect batch ef-
fects, a principal component analysis was performed,
based on the 10,000 sites with highest variance. The first
5 principal components (PC) were extracted. Extracted
PCs were tested for association with possible batch ef-
fects using MANOVA and visual inspection of scatter
plots. Detected batch effects were then removed using
the ComBat procedure, as implemented in the sva
package [54]. Following the removal of Sentrix ID and
position related effects, no further batch effects were evi-
dent. Cell type composition was estimated using the
Houseman reference based method, as implemented in
the minfi package [55]. Adjustment for cell type com-
position was then performed by including the first five
of a total of six cell type estimators as covariates in the
regression models used for association testing.
Methylation association analysis
To avoid introducing additional heterogeneity with
regard to birth weight, mothers whose pregnancy was
complicated by premature delivery (gestational age <259
days) or treatment for gestational diabetes were excluded
prior to analysis. To minimize the risk of spurious
associations due to small sample size and thus avoid
false positives, the analysis was strictly limited to high
confidence smoking-related CpG sites that had shown
significant association with smoking in a large recent
meta-analysis [31], and CpG sites previously reported to
mediate the effect of maternal smoking on birth weight
[37, 38]. Association testing for methylation levels was
performed using general linear models as implemented
in the R-package limma. Gestational age, sex of the new-
born, and parental height were included as covariates,
since research has shown that these factors impact
birth weight [56]. Adjustment was also made for mater-
nal age. Cell type composition was taken into account,
as described above. Sex and gestational age (weeks) were
reported by the responsible obstetrician. Sex specific
analyses were then conducted using the covariates
above, with the exception of sex.
To exclude other significant loci in this sample, we
also performed an EWAS on smoking (data not shown).
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Mediation analysis
Sites showing significant association with smoking
(FDR<0.05) were then used to test whether methylation
levels partly mediate the effects of maternal smoking on
birth weight. This was performed using a quasi-Bayesian
approach as proposed in Imai et al. ([57]; for a more
detailed explanation please see Additional file 1: Text),
as implemented in R-package mediation [57], running
10,000 simulations. The same possible confounders as
named above were included as additional covariates in
the mediator and outcome regression models (gesta-
tional age, sex of the newborn, parental height, maternal
age, cell type composition; in contrast to Kupers et al.
[37] socioeconomic status was not included in the model
as it was not associated with birth weight in our sample).
For sex specific analyses sex of newborn was excluded
from the models as above.
Gene-based analysis of Early Growth Genetics (EGG)
Consortium GWAS results
Data on the trait “birth weight” were obtained from the
EGG Consortium via the UK Biobank Resource. These
data were downloaded from www.egg-consortium.org
[58]. Gene-based analysis was performed using the ´birth
weight summary statistic data 2016´ (file: BW3_EUR_
summary_stats.txt.gz from http://egg-consortium.org/
birth-weight-2016.html) and MAGMA v1.06[59]. The
applied linkage disequilibrium (LD) structure was that of
the 1000 Genomes project (http://www.internationalgen-
ome.org/data). SNPs were assigned to a gene if the vari-
ant was located within 20kb flanking its transcript.
Results
After technical QC, a total of 405,654 sites and 311
individuals were in principle available for analysis. A
total of n=5,527 of these CpG sites had previously been
reported associated with smoking (see above) and were
therefore selected for association testing. After excluding
prematurely delivered newborns and individuals receiv-
ing anti-diabetic treatment during pregnancy the final
sample size was n=282 individuals (138 male and 144
female). Of these, 13 males and 12 females were the
offspring of mothers who had smoked throughout
pregnancy. The general characteristics of the partici-
pants included in the present study are provided in
Additional file 1: Table S1.
Impact of maternal smoking on birth weight
a) The average difference in birth weight between the
smoking and non-smoking groups was 209g. The
newborns of smokers had a mean birth weight of
3,267g. The newborns of non-smokers had a mean
weight of 3,476g (see Table 1; see also Additional
file 1: Figure S2 for a more fine grained comparison
between different groups).
b) In female newborns (n=144), the average birth
weight was 189g lower in the smoking subgroup
compared to the non-smoking subgroup, i.e.,
birth weight was 5.6% lower when mothers smoked.
This difference however did not reach statistical sig-
nificance. In male newborns (n=138), the average
birth weight was significantly lower by 242g in the
smoking subgroup compared to the non-smoking
subgroup, i.e., birth weight was 6.7% lower when
mothers smoked (see Table 1).
Methylation association analysis
Following correction for multiple testing, a total of 30
CpG sites showed significant differential methylation in
the smoking subgroup (see Table 2). These CpGs map to
13 genes (AHRR, CNTNAP2, CYP1A1, FRMD4A, GFI1,
ITGB7, MIR548F3, MYO1G, PIM1, RNF157, SAMD3,
TFEB, UNC45B).
The EWAS on smoking revealed no further epigenome-
wide associated CpG sites (data not shown.
There was no significant association between DNA
extraction method and methylation levels using a linear
modelling approach as well as including the extraction
methods as a covariate (data not shown).
Mediation analysis
Of the 30 CpG sites found differentially methylated after
maternal smoking in our sample, the following were
found to mediate the effect of maternal smoking on
birth weight: cg25325512 (PIM1, p=0.005); cg25949550
(CNTNAP2, p=0.008); and cg08699196 (ITGB7, p=0.
045). Sex-specific analyses for these three CpG sites re-
vealed that cg25949550 (CNTNAP2, p=0.022) mediated
the effect of maternal smoking on birth weight in male
newborns (see Table 3).
Gene-based analysis of EGG Consortium GWAS results
In the gene-based-analysis, PIM1, CNTNAP2, and ITGB7
were tested for association with birth weight. ITGB7
showed significant association (p=8.24x10-7). PIM1 and
CNTNAP2 failed to achieve nominal significance (p>0.05).
Single marker p-values of the SNPs at the ITGB7 locus
are listed in Additional file 1: Table S2.
Discussion
The aims of the present study were to replicate the
finding that the association between maternal smoking
and birth weight is mediated by methylation, and to
investigate whether the observed mediation effects are
sex-specific. Differentially methylated CpG sites were
detected in 13 genes, including AHRR, GFI1, MYO1G,
CYP1A1, and CNTNAP2. These represent the top five
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Table 1 Average birth weight of newborns
Smoking subgroup (n=25) Non-smoking subgroup (n=257) Mean difference p-valuec
Birth weight 3,267g (437)a 3,476g (455)a 209 (21 – 396)b 0.03
Birth weight females 3,172g (500)a 3,361g (428)a 189 (-135 – 512)b 0.23
Birth weight males 3,355g (367)a 3,597g (452)a 242 (10 – 474)b 0.04
aMean values (Standard deviation)
b95%-CI, two-sided
cWelch t-test










cg04865726 1 1365911 S_Shelf 0,033 5,39E-05 1,65E-02
cg09662411 1 92946132 GFI1 Body Island -0,115 3,69E-07 3,98E-04
cg06338710 1 92946187 GFI1 Body Island -0,099 2,26E-05 8,94E-03
cg18146737 1 92946700 GFI1 Body Island -0,128 7,51E-07 5,19E-04
cg12876356 1 92946825 GFI1 Body Island -0,178 1,07E-06 6,55E-04
cg18316974 1 92947035 GFI1 Body Island -0,057 4,32E-07 3,98E-04
cg09935388 1 92947588 GFI1 Body Island -0,194 2,72E-09 7,52E-06
cg14179389 1 92947961 GFI1 Body Island -0,061 5,07E-08 9,34E-05
cg11641006 2 235213874 0,078 1,40E-05 6,45E-03
cg23067299 5 323907 AHRR Body S_Shore 0,031 7,71E-05 2,17E-02
cg23916896 5 368804 AHRR Body N_Shore -0,025 2,12E-04 4,22E-02
cg11902777 5 368843 AHRR Body N_Shore -0,005 1,99E-04 4,22E-02
cg05575921 5 373378 AHRR Body N_Shore -0,075 1,24E-15 6,85E-12
cg21161138 5 399360 AHRR Body -0,043 2,63E-05 9,68E-03
cg25325512 6 37142220 PIM1 3'UTR S_Shelf -0,062 1,52E-04 3,65E-02
cg23594693 6 41703970 TFEB 5'UTR;TSS1500;1stExon S_Shore 0,027 1,32E-04 3,46E-02
cg02227813 6 130524018 SAMD3; SAMD3 Body 0,040 7,86E-05 2,17E-02
cg07249149 7 1035363 -0,051 1,77E-04 3,91E-02
cg19089201 7 45002287 MYO1G 3'UTR Island 0,028 1,29E-05 6,45E-03
cg22132788 7 45002486 MYO1G Body Island 0,019 2,14E-04 4,22E-02
cg04180046 7 45002736 MYO1G Body Island 0,063 5,31E-07 4,19E-04
cg12803068 7 45002919 MYO1G Body S_Shore 0,109 1,56E-05 6,64E-03
cg25949550 7 145814306 CNTNAP2 Body S_Shore -0,009 8,90E-08 1,23E-04
cg15578140 7 147718109 MIR548F3;CNTNAP2 Body 0,054 8,01E-06 4,43E-03
cg11813497 10 14372879 FRMD4A TSS200 0,043 1,39E-04 3,49E-02
cg26033520 10 74004071 -0,026 2,63E-04 4,84E-02
cg08699196 12 53591398 ITGB7 Body Island 0,028 2,50E-04 4,77E-02
cg05549655 15 75019143 CYP1A1 TSS1500 Island 0,021 4,76E-05 1,56E-02
cg13859324 17 33474692 UNC45B TSS200;TSS200 0,032 4,79E-05 1,56E-02
cg11043990 17 74235759 RNF157 Body Island 0,017 1,60E-04 3,69E-02
aBeta-Value Mean-Differences between Smoking vs Non-Smoking group
bFalse discovery rate
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differentially methylated genes reported in adult smokers
[16–18, 60, 61], and in previous studies of newborns
exposed to maternal smoking [25–27, 31, 32, 37].
Mediation analysis of the 30 CpG sites revealed that
CpG sites in the genes PIM1, CNTNAP2, and ITGB7
mediated the effect of maternal smoking on
birth weight in the complete sample. The serine/
threonine-protein kinase PIM1 has a marked anti-
apoptotic effect, and its level is increased in lung tis-
sue following exposure to cigarette smoke [62].
Interestingly, it has been shown that an enhanced
gene expression of PIM1 - corresponding to a de-
creased methylation level - protects against cell death
induced by cigarette smoke and neutrophilic airway
inflammation [62]. In our sample, the methylation
level of cg25325512 in PIM1 is lower in smokers than
in non-smokers. A lower methylation level can lead
to an upregulation of gene expression. Thus, upregu-
lation of PIM1 in smokers could be an adaptive
process to protect against negative effects of cigarette
Table 3 Results of mediation analysis






cg04865726 - 19.1 0.363 - 189 0.031 - 208 0.014 0.367 0.033 0.023
cg09662411 4.6 0.864 - 213 0.016 - 208 0.016 0.860 0.019 0.023
cg06338710 - 5.6 0.797 - 203 0.027 - 208 0.017 0.802 0.023 0.023
cg18146737 - 30.6 0.252 - 177 0.048 - 208 0.016 0.241 0.049 0.023
cg12876356 - 36.4 0.154 - 172 0.057 - 208 0.014 0.165 0.055 0.023
cg18316974 - 31.4 0.248 - 176 0.053 - 207 0.017 0.248 0.049 0.023
cg09935388 - 46.0 0.149 - 160 0.078 - 206 0.018 0.148 0.077 0.023
cg14179389 - 53.8 0.061 - 154 0.085 - 208 0.015 0.065 0.087 0.023
cg11641006 13.6 0.559 - 221 0.014 - 207 0.017 0.565 0.013 0.023
cg23067299 23.8 0.254 - 232 0.008 - 209 0.012 0.246 0.009 0.023
cg23916896 8.4 0.663 - 217 0.010 - 209 0.012 0.661 0.014 0.023
cg11902777 4.0 0.856 - 211 0.015 - 207 0.013 0.848 0.017 0.023
cg05575921 - 38.0 0.400 - 171 0.077 - 209 0.015 0.386 0.080 0.023
cg21161138 - 2.0 0.928 - 206 0.019 - 208 0.015 0.927 0.021 0.023
cg25325512 - 56.3 0.005 - 152 0.082 - 209 0.017 0.005 0.081 0.023
cg23594693 - 6.2 0.767 - 200 0.023 - 207 0.017 0.763 0.023 0.023
cg02227813 - 22.9 0.275 - 186 0.035 - 209 0.015 0.276 0.036 0.023
cg07249149 - 19.7 0.323 - 189 0.030 - 209 0.014 0.332 0.032 0.023
cg19089201 - 15.7 0.495 - 191 0.031 - 207 0.016 0.500 0.031 0.023
cg22132788 - 5.7 0.766 - 202 0.023 - 208 0.015 0.772 0.022 0.023
cg04180046 - 14.0 0.606 - 193 0.031 - 207 0.017 0.604 0.031 0.023
cg12803068 6.3 0.785 - 214 0.014 - 208 0.015 0.774 0.016 0.023
cg25949550 75.7 0.008 - 283 0.002 - 208 0.017 0.009 0.002 0.023
cg15578140 - 14.7 0.530 - 194 0.029 - 209 0.012 0.523 0.031 0.023
cg11813497 18.5 0.353 - 227 0.009 - 208 0.016 0.366 0.010 0.023
cg26033520 29.7 0.123 - 239 0.008 - 210 0.015 0.121 0.007 0.023
cg08699196 - 39.6 0.045 - 169 0.051 - 208 0.013 0.043 0.055 0.023
cg05549655 1.1 0.956 - 209 0.017 - 208 0.016 0.967 0.019 0.023
cg13859324 - 18.4 0.401 - 190 0.029 - 209 0.012 0.401 0.033 0.023
cg11043990 - 28.7 0.173 - 177 0.042 - 206 0.017 0.169 0.042 0.023
aAverage causal mediation effect in g
bAverage direct effect in g
cTotal effect of smoking on birth weight (ACME+ADE)
dAssociation between birth weight and methylation after adjustment for smoking and covariates
eAssociation between birth weight and sustained maternal smoking after adjustment for methylation and covariates
fAssociation between maternal smoking and birth weight after adjustment for covariates, irrespective of methylation levels
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smoking. In monkeys, research has shown that PIM1 is
associated with body mass indeces after calorie restriction
[63]. PIM1 belongs to the PIM serine/threonine kinase
family, which is involved in the regulation of cell survival.
PIM kinases are constitutively active, and regulate cell
growth, differentiation, and apoptosis [64]. The Contactin
Associated Protein-Like 2 gene (CNTNAP2) encodes a
member of the neurexin family, whose members function
as cell adhesion molecules and receptors in the nervous
system of vertebrates. Genetic variation in CNTNAP2 has
been associated with the regulation of body weight [65].
Interestingly, research has also implicated CNTNAP2 in
multiple neurodevelopmental disorders, including Gilles de
la Tourette syndrome, schizophrenia, epilepsy, autism, at-
tention deficit and hyperactivity disorder, and mental re-
tardation [66]. CNTNAP2 may play a role in the formation
of functionally distinct domains critical for the saltatory
conduction of nerve impulses in myelinated nerve fibers.
The methylation level of the mediating CpG cg25949550
in CNTNAP2 is lower in infants whose mothers smoked
during pregnancy, presumably leading to higher gene ex-
pression. As loss of CNTNAP2 has been shown to lead to
deficits in axonal excitability [67], lower methylation
of this gene might also be an adaptive process to pro-
tect against negative effects of cigarette smoking. The
Integrin Subunit Beta 7 gene (ITGB7) encodes a pro-
tein that is a member of the integrin superfamily.
Members of this family are adhesion receptors, which
are involved in signaling from the extracellular matrix
to the cell. High expression of ITGB7 has been found
to be associated with poor survival of cancer cells
[68]. In the present study, the methylation level of
cg08699196 in ITGB7 is increased, which may reduce
its gene expression. A reduction in of ITGB7 expres-
sion might result in higher survival of cancer cells
and, thus, oncogenesis.
The genes PIM1, CNTNAP2, and ITGB7 were not
implicated in previous EWAS of birth weight [69–71].
However, in a gene-based analysis of genetic data
obtained from a genome-wide association analysis of
birth weight by the EGG Consortium [58], the present
authors found that ITGB7 was strongly associated with
birth weight (p=4, 2x10-7). Furthermore, ITGB7 was
found to be associated with the pathophysiology of
childhood obesity in a Hispanic population [72].
As methylation levels are known to be sex-specific
already at birth, the present study involved sex-
specific mediation analyses. Unsurprisingly, these sug-
gest that the mediation effects can also be dependent
on sex. The CpG site in CNTNAP2 had a more
pronounced effect in male newborns, and failed to reach
significance in females. Further sex-specific mediation
effects are possible. However, their detection will require
larger samples.
In contrast to previous studies, parental height was
included as a covariate in the present analyses, as it had
a pronounced influence on birth weight in our study.
Performance of the analysis without this covariate did
indeed obtain 45 rather than 30CpG sites associated
with smoking. In the mediation analysis of these 45 CpG
sites, three further sites became significant in addition to
PIM1 and CNTNAP2 (see Additional file 1: Table S3). De-
termining whether the respective findings are true or false
positives is problematic, and can only be resolved through
the performance of larger studies and metaanalyses.
The present study had several limitations in terms of
the investigated smoking phenotype. Smoking status was
conceptualized as a dichotomized trait, and no distinc-
tion was made between light and heavy smokers.
Furthermore, smoking was assessed using retrospective
self-reports rather than prospective and objective mea-
sures such as cotinine levels. This may have led to an
underestimation of the number of smoking mothers,
and thus to an underestimation of the direct effect, and
an overestimation of the mediation effect, of smoking.
This phenomenon was reported recently by Valeri et al.
in a study on the Norwegian MoBa cohort [73]. How-
ever, unreliable self-reporting of smoking status in the
present cohort is unlikely for two reasons. First, the
subjects had a high relationship of confidence as they
received regular obstetric care at the recruitment centers
throughout pregnancy. Second, the direct effect of
smoking on birth weight in the present cohort (average
reduction in birth weight of ~200g) was more pro-
nounced than that reported in the MoBa study of Valeri
et al (~90g). The rate of false self-reporting is likely to
be in accordance with rates reported in previous studies.
Conclusions
The present study supports reported findings that
DNA methylation may represent a biological mechanism
through which maternal smoking impacts birth weight.
Unsurprisingly, this effect may be sex-dependent, as sug-
gested for the first time in the present analyses. Further
studies are warranted to investigate the role of the
identified differentially methylated loci in mediating the as-
sociation between maternal smoking during pregnancy and
birth weight, and their role in determining offspring pheno-
types in later life.
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